跳至主要内容
临床试验/JPRN-UMIN000051350
JPRN-UMIN000051350招募中Unknown

Efficacy of angiotensin II receptor blocker versus sacubitril valsartan on Blood pressure and glycemic control measured by continuous glucose monitoring in adults with type 2 diabetes complicated by hypertension - Efficacy of angiotensin II receptor blocker versus sacubitril valsartan on Blood pressure and glycemic control measured by continuous glucose monitoring in adults with type 2 diabetes complicated by hypertension

Tochigi Medical Center Shimotsuga0 个研究点目标入组 40 人开始时间: 2023年6月20日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients diagnosed with type 1 diabetes Individuals who have a hypersensitivity to Sacubitril valsartan or angiotensin II receptor blockers History of angioedema severe renal dysfunction (eGFR < 30 mL/min/1.73 m2) severe hepatic dysfunction (Child-Pugh classification C) pregnant women, or individuals who may be pregnant other patients who the physician deems unsuitable should avoid using this medication.

研究者

发起方
Tochigi Medical Center Shimotsuga

相似试验